Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP

Cancer Research

Volumn 57, Issue 2, 1997, Pages 290-294

  VanderSpek, Johanna C ^a,c   Sutherland, John A ^a   Zeng, Huiyan ^a   Battey, James F ^b   Jensen, Robert T ^b   Murphy, John R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DIPHTHERIA TOXIN; GASTRIN RELEASING PEPTIDE; HYBRID PROTEIN; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CYTOTOXICITY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CARCINOMA, SMALL CELL; DIPHTHERIA TOXIN; ENZYME INHIBITORS; HUMANS; LUNG NEOPLASMS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 0031032027     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., and Minna, J. D. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature (Lond.) 316: 823-826, 1985.
2. Carney, D. N., Cuttitta, F., Moody, T. W., and Minna, J. D. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res., 47: 821-825, 1987.
3. Giaccone, G., Battey, J., Gazdar, A. F., Oie, H., Draoui, M., and Moody, T. W. Neuromedin B is present in lung cancer cell lines. Cancer Res., 52 (Suppl.): 2732s-2736s. 1992.
4. Schutte, J., and Seeber, S. Bombesin antagonists: experimental and clinical results. Recent Results Cancer Res., 129: 115-129, 1993.
5. Corjay, M. H., Dobrzanski, D. J., Way, J. M., Viallet, J., Shapira, H., Worland, P., Sausville, E. A., and Battey, J. F. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma. J. Biol. Chem., 266: 18771-18779, 1991.
6. Radulovic, S., Miller, G., and Schally, A. V. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res., 51: 6006-6009, 1991.
7. Frucht, H., Gazdar, A, F., Park, J-A., Oie, H., and Jensen, R. T. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res., 52: 1114-1122, 1992.
8. 6]-luteinizing hormone-releasing hormone and somatostatin analogue RC-160. Prostate, 20: 269-280, 1992.
9. Yano, T., Pinski, J., Groot, K., and Schally, A. V. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res., 52: 4545-4547, 1992.
10. Williams, B. Y., and Schonbrunn, A. Bombesin receptors in a human duodenal tumor cell line: binding properties and function. Cancer Res., 54: 818-824, 1994.
11. Pinski, J., Halmos, G., and Schally, A. V. Somatostatin analog RC-160 and bombesin/ gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett., 71: 189-196, 1993.
12. 13,14]Bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res., 51: 1798-1802, 1991.
13. Bunn, P. A., Jr., Chan, D., Stewart, J., Gera, L., Tolley, R., Jewett, P., Tagawa, M., Alford, C., Mochzuki, T., and Yanaihara, N. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines. Cancer Res., 54: 3602-3610, 1994.
14. Kroog, G. S., Sainz, E., Worland, P. J., Akeson, M. A., Benya, R. V., Jensen, R. T., and Battey, J. F. The gastrin-releasing peptide receptor is rapidly phosphorylated by a kinase other than protein kinase C after exposure to agonist. J. Biol. Chem., 270: 8217-8214, 1995.
15. Fisher, C. E., Sutherland, J. A., Krause, J. E., Murphy, J. R., Leeman, S. E., and vanderSpek, J. C. Genetic construction and properties of a diphtheria toxin-related substance P fusion protein: in vitro destruction of cells bearing substance P receptors. Proc. Natl. Acad. Sci. USA. 93: 7341-7345, 1996.
16. 389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. J. Biol. Chem., 268: 12077-12082, 1993.
17. Killeen, K. P., Escuyer, V., Mekalanos, J. J., and Collier, R. J. Reversion of recombinant toxoids: mutations in diphtheria toxin that partially compensate for active-site deletions. Proc. Natl. Acad. Sci. USA, 89: 6207-6209, 1992.
18. Sausville, E. A., Mover, J. D., Heikkila, R., Neckers, L. M., and Trepel, J. B. A correlation of bombesin-responsiveness with myc-family gene expression in small cell lung carcinoma cell lines. Ann. NY Acad. Sci., 547: 310-321, 1988.
19. Moody, T. W., Staley, J., Zia, F., Coy, D. H., and Jensen R. T. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. J. Pharmacol. Exp. Ther., 263: 311-317, 1992.
20. 11]substance P. J. Biol. Chem., 270: 8623-8628, 1995.
21. Merkler, D. J. C-terminal amidated peptides: production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity. Enzyme Microb. Technol., 16: 450-456, 1994.
22. 389 EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J. Biol. Chem., 266: 12449-13455, 1991.
23. Pastore, C. J., Isner, J., Bacha, P. A., Kearney, M., and Pickering, G. Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo. Circ. Res., 77: 519-529, 1995.
24. Moody, T. W., Bertness, V., and Carney, D. N. Bombesin-like peptides and receptors in human cell lines. Peptides 4: 683-686, 1983.